Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.

Revenue
+2.75%
EPS
−500.0%
Free cash flow
−60.6%
Total debt
+4.92%

Quarter to June 2026, against a year earlier

23.18 0.02 +0.09%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
−35.3×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100

Surgery Partners, Inc. (SGRY) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Surgery Partners, Inc. (SGRY) trades at a EV/FCF of 34.1×. Over the past ten years it has ranged from 12.1× (July 2020) to 227× (December 2021); the current reading is higher than 63% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 22.4× (17.52%)
FY2024 27.2× (4.25%)
FY2023 28.4× (45.63%)
FY2022 52.2× (71.11%)
FY2021 181× 1,100.12%
FY2020 15.1× (65.87%)
FY2019 44.1× 109.50%
FY2018 21.1× (27.67%)
FY2017 29.1× 18.52%
FY2016 24.6× (35.22%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 29.8× 46.80%
Mar 2026 20.3× (9.58%)
Dec 2025 22.4× (12.68%)
Sep 2025 25.7× (8.42%)
42 more quarters

Against its own ten years

Low 12.1× High 227×
Ten-year median 30.1×
Current reading's percentile 65

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on SGRY